Evicenter
P&T meetings

Deramiocel (CAP-1002)

Duchenne muscular dystrophy

Launch
Not announced
Last updated
92 sources

Product information and disease descriptionPlace of product in therapy

Approaches to treatment

22 evidence topics · 16 sources

Other product development or post-marketing obligations required by the FDA

Not applicable.

Ongoing post-approval monitoring

Not applicable.